Atherosclerosis plus最新文献

筛选
英文 中文
Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study 洛米他匹治疗小儿同型家族性高胆固醇血症患者--APH-19 研究疗效阶段的结果
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.008
L. Masana , A. Zambon , C.P. Schmitt , C. Taylan , J. Driemeyer , H. Cohen , P.S. Buonuomo , A. Alashwal , M. Al-Dubayee , J.L. Diaz-Diaz , F. Maatouk , S. Martínez Hervás , B. Mangal , S. Löwe , T. Cunningham
{"title":"Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study","authors":"L. Masana , A. Zambon , C.P. Schmitt , C. Taylan , J. Driemeyer , H. Cohen , P.S. Buonuomo , A. Alashwal , M. Al-Dubayee , J.L. Diaz-Diaz , F. Maatouk , S. Martínez Hervás , B. Mangal , S. Löwe , T. Cunningham","doi":"10.1016/j.athplu.2023.07.008","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.008","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S9"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000214/pdfft?md5=2a14141782d2235b65cba0f09acb3090&pid=1-s2.0-S2667089523000214-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/S2667-0895(23)00044-5
{"title":"Title Page","authors":"","doi":"10.1016/S2667-0895(23)00044-5","DOIUrl":"https://doi.org/10.1016/S2667-0895(23)00044-5","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S1"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000445/pdfft?md5=cd26e98c500971e30ef10f529aac93d4&pid=1-s2.0-S2667089523000445-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia 洛米他匹肝安全性:对同型家族性高胆固醇血症患者的长期回顾性分析
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.014
J. Cegla , D. Larrey , L. D’Erasmo , S. O’Brien , M. Arca
{"title":"Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia","authors":"J. Cegla , D. Larrey , L. D’Erasmo , S. O’Brien , M. Arca","doi":"10.1016/j.athplu.2023.07.014","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.014","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Pages S2-S3"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000275/pdfft?md5=9b089c9e8274cdaa5af6d637573ccea1&pid=1-s2.0-S2667089523000275-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HEART UK 2023 Moderated Posters HEART UK 2023 主持人海报
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.010
{"title":"HEART UK 2023 Moderated Posters","authors":"","doi":"10.1016/j.athplu.2023.07.010","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.010","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S11"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000238/pdfft?md5=8ab2ab543e2328f4891ea02b30894c85&pid=1-s2.0-S2667089523000238-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HEART UK 2023 Oral Presentations HEART UK 2023 口头报告
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.022
{"title":"HEART UK 2023 Oral Presentations","authors":"","doi":"10.1016/j.athplu.2023.07.022","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.022","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Pages S5-S6"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000354/pdfft?md5=b63f3a0b2e0e0e35ec4ddf66368bd10d&pid=1-s2.0-S2667089523000354-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition? 要实现国家医疗服务体系 2019 年长期计划的目标,需要确定多少名家族性高胆固醇血症 (FH) 患者?
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.016
S.E. Humphries , J.Gratton , K. Haralambos , M. Futema
{"title":"How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?","authors":"S.E. Humphries , J.Gratton , K. Haralambos , M. Futema","doi":"10.1016/j.athplu.2023.07.016","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.016","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S3"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000299/pdfft?md5=32cbc6cfa7745c37eaf3ff4a3f35e8ea&pid=1-s2.0-S2667089523000299-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How many FH genetic tests were performed by the UK Genetic Laboratory Hubs in 2022? 2022 年,英国基因实验室中心进行了多少次 FH 基因检测?
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.005
S.E. Humphries , R. Challis , K. Downes , E. Howard , T. Legerton , C. Macanulty , S. Morgan , A. O’Rouke , D. O’Sullivan , A. Taylor-Beadling , E. Thompson , E. Watson , G. Norbury
{"title":"How many FH genetic tests were performed by the UK Genetic Laboratory Hubs in 2022?","authors":"S.E. Humphries , R. Challis , K. Downes , E. Howard , T. Legerton , C. Macanulty , S. Morgan , A. O’Rouke , D. O’Sullivan , A. Taylor-Beadling , E. Thompson , E. Watson , G. Norbury","doi":"10.1016/j.athplu.2023.07.005","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.005","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S9"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000184/pdfft?md5=e02bd551faecb97e687ddbb511b0731f&pid=1-s2.0-S2667089523000184-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial Chylomicronaemia Syndrome (FCS) Compared to Multifactorial Chylomicronaemia Syndrome (MCS) – Lessons learnt from United Kingdom FCS Registry 家族性乳糜微粒血症综合征(FCS)与多因素乳糜微粒血症综合征(MCS)的比较--从英国 FCS 登记中汲取的经验教训
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.018
B. Bashir , S. Kwok , A.S. Wierzbicki , A. Jones , C. Dawson , P. Downie , F. Jenkinson , P. Gupta , M. Mansfield , R. Kumari , D. Datta , H. Delaney , Y. Teoh , M. Williams , N. Forrester , D. O’Sullivan , Z. Miedzybrodzka , J. Payne , H. Soran
{"title":"Familial Chylomicronaemia Syndrome (FCS) Compared to Multifactorial Chylomicronaemia Syndrome (MCS) – Lessons learnt from United Kingdom FCS Registry","authors":"B. Bashir , S. Kwok , A.S. Wierzbicki , A. Jones , C. Dawson , P. Downie , F. Jenkinson , P. Gupta , M. Mansfield , R. Kumari , D. Datta , H. Delaney , Y. Teoh , M. Williams , N. Forrester , D. O’Sullivan , Z. Miedzybrodzka , J. Payne , H. Soran","doi":"10.1016/j.athplu.2023.07.018","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.018","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S4"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000317/pdfft?md5=c6e645e7bc21bd015414a43806f2cb6d&pid=1-s2.0-S2667089523000317-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial Chylomicronaemia Syndrome (FCS) Score Validation in United Kingdom FCS Registry: Can Additional Variables Improve the FCS Score Performance? 家族性乳糜微粒血症综合征(FCS)评分在英国 FCS 登记处的验证:附加变量能否提高 FCS 评分的性能?
IF 1.6
Atherosclerosis plus Pub Date : 2023-12-01 DOI: 10.1016/j.athplu.2023.07.004
B. Bashir , S. Kwok , A.S. Wierzbicki , A. Jones , C. Dawson , P. Downie , F. Jenkinson , P. Gupta , H. Dealeny , M. Mansfield , R. Kumari , D. Datta , Y. Teoh , M. Williams , N. Forrester , D. O’Sullivan , Z. Miedzybrodzka , A. Gallo , P. Moulin , J. Payne , H. Soran
{"title":"Familial Chylomicronaemia Syndrome (FCS) Score Validation in United Kingdom FCS Registry: Can Additional Variables Improve the FCS Score Performance?","authors":"B. Bashir , S. Kwok , A.S. Wierzbicki , A. Jones , C. Dawson , P. Downie , F. Jenkinson , P. Gupta , H. Dealeny , M. Mansfield , R. Kumari , D. Datta , Y. Teoh , M. Williams , N. Forrester , D. O’Sullivan , Z. Miedzybrodzka , A. Gallo , P. Moulin , J. Payne , H. Soran","doi":"10.1016/j.athplu.2023.07.004","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.07.004","url":null,"abstract":"","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Page S8"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000172/pdfft?md5=644746d76cf8a7bc9655fbb8659571e5&pid=1-s2.0-S2667089523000172-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138713219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ITGB2 is a central hub-gene associated with inflammation and early fibro-atheroma development in a swine model of atherosclerosis 在猪动脉粥样硬化模型中,ITGB2是一个与炎症和早期纤维动脉粥样硬化发展相关的中心枢纽基因
IF 1.6
Atherosclerosis plus Pub Date : 2023-11-15 DOI: 10.1016/j.athplu.2023.11.001
Hadjer Namous , Maria Giuseppina Strillacci , Camila Urbano Braz , Dhanu Shanmuganayagam , Christian Krueger , Athanasios Peppas , William C. Soffregen , Jess Reed , Juan F. Granada , Hasan Khatib
{"title":"ITGB2 is a central hub-gene associated with inflammation and early fibro-atheroma development in a swine model of atherosclerosis","authors":"Hadjer Namous ,&nbsp;Maria Giuseppina Strillacci ,&nbsp;Camila Urbano Braz ,&nbsp;Dhanu Shanmuganayagam ,&nbsp;Christian Krueger ,&nbsp;Athanasios Peppas ,&nbsp;William C. Soffregen ,&nbsp;Jess Reed ,&nbsp;Juan F. Granada ,&nbsp;Hasan Khatib","doi":"10.1016/j.athplu.2023.11.001","DOIUrl":"https://doi.org/10.1016/j.athplu.2023.11.001","url":null,"abstract":"<div><h3>Background and aim</h3><p>The complex dynamic interplay between different biological pathways involved in atherosclerosis development has rendered the identification of specific therapeutic targets a challenging quest. We aimed to identify specific genes and mechanistic pathways associated with the early development of fibro-atheromas in a swine model of atherosclerosis.</p></div><div><h3>Methods</h3><p>The Wisconsin Miniature Swine™ model of Familial Hypercholesterolemia (WMS-FH, n = 11) and genetically related WMS controls (WMS-N, n = 11) were used. The infrarenal aorta was harvested from both groups for histopathologic and transcriptomic profiling at 12 months. Bioinformatic analysis was performed to identify hub genes and pathways central to disease pathophysiology. The expression of ITGB2, the top ranked hub gene, was manipulated in cell culture and the expression of interconnected genes was tested.</p></div><div><h3>Results</h3><p>Fibro-atheromatous lesions were documented in all WMS-FH aortic tissues and displayed internal elastic lamina (IEL) disruption, significant reduction of myofibroblast presence and disorganized collagen deposition. No fibro-atheromas were observed in the control group. A total of 266 differentially expressed genes (DEGs) were upregulated in WMS-FH aortic tissues, while 29 genes were downregulated. Top identified hub genes included ITGB2, C1QA, LCP2, SPI1, CSF1R, C5AR1, CTSS, MPEG1, C1QC, and CSF2RB. Overexpression of ITGB2 resulted in elevated expression of other interconnected genes expressed in porcine endothelial cells.</p></div><div><h3>Conclusion</h3><p>In a swine translational model of atherosclerosis, transcriptomic analysis identified ITGB2 as a central hub gene associated inflammation and early fibroatheroma development making it a potential therapeutic target at this stage of disease.</p></div>","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"54 ","pages":"Pages 30-41"},"PeriodicalIF":1.6,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667089523000433/pdfft?md5=320bdbb10453fa6086111075d9285e05&pid=1-s2.0-S2667089523000433-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138437068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信